3 patents
Utility
Dactinomycin compositions and methods for the treatment of myelodysplastic syndrome and acute myeloid leukemia
13 Apr 21
The disclosure provides compositions comprising dactinomycin, formulated for delivery by nanoparticle, and methods for treating a myelodysplastic syndrome (MDS) or cancer, for example, NPM1-mutated acute myeloid leukemia (AML), by administration of the compositions of the disclosure.
Kunwar Shailubhai
Filed: 13 Sep 17
Utility
Formulations of milciclib and therapeutic combinations of the same for use in the treatment of cancer
31 Aug 20
This application relates to methods of treating and/or preventing cancer (e.g., non-small cell lung cancer, renal cell carcinoma, hepatocellular carcinoma, thyroid carcinoma, colorectal cancer, gastrointestinal stromal tumors, breast cancer, prostate cancer, pancreatic cancer, or thymoma) in patients in need thereof comprising administering to the patient a therapeutically effective amount of a CDK inhibitor (e.g., milciclib) in combination with a therapeutically effective amount of another anticancer drug (e.g., sorafenib, lenvatinib, regorafenib, sunitinib, nivolumab, gemcitabine, and palbociclib).
Kunwar Shailubhai
Filed: 5 Nov 18
Utility
Anti-CD3 antibody formulations
22 Jun 20
This invention relates to therapeutic, diagnostic and/or prophylactic formulations and dosages and dosing regimens of anti-CD3 antibodies, as well as to methods for using such formulations and dosages and dosing regimens.
Kunwar Shailubhai
Filed: 28 Aug 17
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first